CLL Prognosis

Ultima Vez Modificado: 8 de enero del 2006

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Researchers Examine Etiology of Ibrutinib Discontinuation in CLL

Feb 27, 2015

Poor prognosis after discontinuation for disease progression, especially Richter's transformation

FDA Expands Imbruvica Approval to Include CLL

Feb 14, 2014

Approval of Imbruvica (ibrutinib) expanded to include people with chronic lymphocytic leukemia

Long-Term Remissions of CLL in First Personalized Cell Tx Trial

Sep 3, 2015

T cells reprogrammed to contain chimeric antigen receptor targeting CD19 protein on B cells